Other signaling pathways, including JNK/p38 MAPK, PI3K–AKT, NF-κB, and TGF-β/Smad, also contribute to the pathogenesis of NASH. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatohepatitis.